RWML
BBIO icon

RAFFA WEALTH MANAGEMENT, LLC’s BridgeBio Pharma BBIO Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298 Buy
4
+2
+100% +$140 ﹤0.01% 1222
2026
Q1 		$149 Buy
+2
New +$145 ﹤0.01% 1224

Other funds holding BBIO

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's BBIO Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its BridgeBio Pharma (BBIO) stake by 100% in Q2 2026, buying an estimated $140 and bringing the position to 4 shares worth $298. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in BBIO in Q1 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 4 shares of BridgeBio Pharma worth $298 as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 2 BridgeBio Pharma shares in Q2 2026, an estimated $140.
  • BridgeBio Pharma made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1222 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in BridgeBio Pharma in Q1 2026 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.